Training

Register now

Virtual meeting

Via Zoom

Description

The training is designed to be a guide for addiction providers interested in providing and caring for people who use stimulants including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants as well as evidence-based treatment for people who use stimulants. The session will also talk about the practical implementation of evidence-based treatment for patients who use stimulants in the office-based addiction treatment setting.

Please note that you must have your camera turned on so we can see you during the training in order to be eligible for CEUs.

Intended audience

Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend.

Speakers

Vanessa Loukas, MSN, FNP-C, CARN-AP Nancy Regan, MSN, FNP, CNM

Objectives

Following this training, participants will have the knowledge necessary to:

• Identify the role of psychostimulants in the overdose epidemic and recognize population disparities.
• Describe the impact of stigma associated with stimulant use disorder (StUD).
• Recognize two risk factors for developing StUD and understand the neurobiological changes associated with stimulant use.
• Describe overamping and management of acute stimulant intoxication.
• Identify health risks associated with stimulant use and apply harm reduction interventions.
• Understand interventions to treat acute stimulant intoxication and long term treatment including de-escalation and behavioral interventions.
• Understand the essentials of integrating stimulant treatment into outpatient addiction treatment.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS), Opioid Response Network (ORN)

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

Boston Medical Center grants 3.00 hours, 0.25 of which are classified as pharmacology hours, to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The lecture has been approved by The Network of Professional Education at Boston University School of Social Work, accredited by the Commonwealth of Massachusetts Board of Social Work Registration, to provide 3.00 credit hours.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 3.00 contact hours will be offered to participants who attend the training and complete the evaluation.

Register now